Clinical heterogeneity and tumor control probability
نویسندگان
چکیده
منابع مشابه
Clinical implications of tumor heterogeneity.
Clinical oncologists have long recognized the great variability in the cellular morphology, natural history, and response to therapy of human tumors. Recent progress in molecular biology, biological chemistry, immunology, and other disciplines has now provided scientists with an array of new technologies that has allowed the study of neoplastic disease to go beyond morphologic and clinical desc...
متن کاملThe Role of radiobiological parameters on Tumor control probability (TCP) in prostate cancer
Introduction: The aim of this study was to evaluation radiobiological modeling parameters on tumor control probability (TCP) for prostate cancer in three different models. These parameters included α⁄β ratios and cell surviving fraction at 2 Gy (SF2). Materials and Methods: The Poisson, equivalent uniform dose (EUD) and linear quadratic (LQ) models was used as...
متن کاملChest-wall irradiation by kilovoltage x-rays: Observed local control rate versus predicted radiobiological tumor control probability
Introduction: The high local control rates observed in patients with breast cancer who had been treated by modified radical mastectomy, chemotherapy and chest-wall irradiation using 120 kV X-rays (50 Gy in 25 fractions) motivated us to investigate their observed tumor control probability (TCP) and test a well-established radiobiological TCP model against our data. Mat...
متن کاملTumor control probability predictions for genetic radiotherapy.
PURPOSE Genetic radiotherapy, the combination of gene therapy and radiation therapy, for cancer treatment is evolving from laboratory studies to clinical trials. Genetic radiotherapy involves the viral infection of cells that change the sensitivity of transduced cells to radiation. Because there is no patient outcome data for genetic radiotherapy, prospective models are needed to determine the ...
متن کاملHuman Cancer Modeling: Recapitulating Tumor Heterogeneity Towards Personalized Medicine
Despite diagnostic, preventive and therapeutic advances, growing incidence of cancer and high rate of mortality among patients affected by specific cancer types indicate current clinical measures are not ideally useful in eradicating cancer. Chemoresistance and subsequent disease relapse are believed to be mainly driven by the cell-molecular heterogeneity of human tumors that necessitates perso...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Oncologica
سال: 2010
ISSN: 0284-186X,1651-226X
DOI: 10.3109/0284186x.2010.489571